The IU Angel Network, an investment vehicle of IU Ventures, today announced an investment in PrecisionCare AI, a Boomerang Ventures portfolio company pioneering Quantifiable Soft Tissue Manipulation (QSTM™)–a first-of-its-kind technology delivering objective, data-driven insights for physical therapists. Based on years of research, QSTM is designed to optimize treatment, personalize care, and improve patient outcomes as a new standard in musculoskeletal therapy.
Each year, millions of patients undergo physical therapy, and as many as 80% of those visits include soft tissue manual therapy. Yet today, those treatments remain largely subjective, with few measurable ways to capture treatment history, process, or outcomes. This lack of standardization can lead to inconsistent care and limited clinical evidence. PrecisionCare AI addresses this challenge by combining smart hardware and AI-powered analytics to give therapists real-time feedback and digital records, reducing variability and supporting evidence-based practice.
Full story: IU Angel Network Invests in PrecisionCare AI to Advance Breakthrough in Soft Tissue Therapy – IU Ventures
